Start-Up Spotlight: Pertinax Pharma, Closing In On Wound Care With Slow-Release CHX Tech

A UK drug-delivery firm is bringing its antimicrobial material to the global wound-care market. Pertinax Pharma, a Bristol University spin-out, is the developer of a slow-release technology that provides controlled and sustained delivery of the antiseptic chlorhexidine.